Esperion Therapeutics
ESPR
#6820
Rank
A$0.67 B
Marketcap
$3.46
Share price
8.06%
Change (1 day)
141.63%
Change (1 year)

Esperion Therapeutics (ESPR) - Cash on Hand

Cash on Hand as of June 2024 : A$0.28 Billion

According to Esperion Therapeutics's latest financial reports the company has A$0.28 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Esperion Therapeutics - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.12 B-50.77%
2022-12-31A$0.24 B-31.45%
2021-12-31A$0.35 B-9.81%
2020-12-31A$0.39 B38.3%
2019-12-31A$0.28 B48.52%
2018-12-31A$0.19 B-24.7%
2017-12-31A$0.25 B-12.64%
2016-12-31A$0.29 B0.74%
2015-12-31A$0.29 B125.3%
2014-12-31A$0.12 B92.06%
2013-12-31A$67.33 M974.63%
2012-12-31A$6.26 M308.94%
2011-12-31A$1.53 M
2002-12-31A$79.61 M-42.19%
2001-12-31A$0.13 B9.65%
2000-12-31A$0.12 B1298.01%
1999-12-31A$8.98 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$1.15 B 303.49%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.41 B 391.51%๐Ÿ‡บ๐Ÿ‡ธ USA
A$15.08 B 5,157.15%๐Ÿ‡บ๐Ÿ‡ธ USA
A$14.85 B 5,075.01%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.37 B 31.93%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.46 B 63.74%๐Ÿ‡บ๐Ÿ‡ธ USA